Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study
Overview
Affiliations
Background: We examined the associations among 8 different fat depots accumulated in various anatomic regions and the relationship between these fat depots and multiple cardiometabolic risk factors.
Methods: Participants were from the Framingham Heart Study Offspring and Third Generation who also participated in the multidetector computed tomography substudy in 2002-2005. Exposures were multidetector computed tomography-derived fat depots, including abdominal subcutaneous adipose tissue, abdominal visceral adipose tissue, intramuscular fat, intrathoracic fat, pericardial fat, thoracic periaortic fat, intrahepatic fat, and renal sinus fat. Multivariable-adjusted regression analyses with a forward selection procedure were performed to identify the most predictive fat depots.
Results: Of 2529 participants, 51.9% were women (mean age, 51.1 years). Visceral adipose tissue had the strongest correlations with each of the other fat measures (range, 0.26-0.77) and with various cardiometabolic risk factors (range, -0.34 to 0.39). As determined by the selection models, visceral adipose tissue was the only fat depot that was associated with all cardiometabolic risk factors evaluated in this study (all P<.05). Selection models also showed that subcutaneous adipose tissue and intrahepatic fat were associated with cardiometabolic risk factors related to the traits of dysglycemia, dyslipidemia, and hypertension (all P<.05). However, only associations with visceral adipose tissue and intrahepatic fat persisted after further adjustment for body mass index and waist circumference.
Conclusions: Visceral adipose tissue and intrahepatic fat were consistent correlates of cardiometabolic risk factors, above and beyond standard anthropometric indices. Our data provide important insights for understanding the associations between variations in fat distribution and cardiometabolic abnormalities.
Wu M, Lai W, Huo X, Wang Q, Zhou Y, Gao D BMC Cardiovasc Disord. 2025; 25(1):160.
PMID: 40055587 PMC: 11887152. DOI: 10.1186/s12872-025-04591-1.
Cybulska A, Schneider-Matyka D, Walaszek I, Panczyk M, Cwiek D, Lubkowska A Front Endocrinol (Lausanne). 2025; 16:1527567.
PMID: 39991740 PMC: 11842235. DOI: 10.3389/fendo.2025.1527567.
Food Chain and Food Policies: Causes and Solutions for the Obesity Pandemic.
Sareen N, Watson S, Hill N, Brandt E, Vijayaraghavan K Methodist Debakey Cardiovasc J. 2025; 21(2):14-22.
PMID: 39990750 PMC: 11843978. DOI: 10.14797/mdcvj.1509.
Hong S, Kim W, Kang E, Jeong I, Kim C, Lee K Diabetes Obes Metab. 2024; 27(3):1242-1250.
PMID: 39703109 PMC: 11802386. DOI: 10.1111/dom.16119.
Webb M, Park J, Day D, Trabulsi J, Sathyanarayana S, Melough M J Endocr Soc. 2024; 8(12):bvae189.
PMID: 39569134 PMC: 11578596. DOI: 10.1210/jendso/bvae189.